Compounds > pramipexole
Page last updated: 2024-09-03

pramipexole and Hyperactivity, Motor

pramipexole has been researched along with Hyperactivity, Motor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YH; Chew, KT; Hsieh, KC; Lai, YY; Nguyen, D; Ramanathan, L; Siegel, JM1
Finsterer, J; Rettensteiner, J1
Breuer, ME; Buerger, E; Ferger, B; Groenink, L; Korte, M; Olivier, B; Oosting, RS1
Buerger, E; Danzeisen, R; Dorner-Ciossek, C; Gillardon, F; Hengerer, B; Klinder, K; Krzykalla, V; Kussmaul, L; Ludolph, AC; Schild, L; Schwalenstoecker, B1

Other Studies

4 other study(ies) available for pramipexole and Hyperactivity, Motor

ArticleYear
Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:12

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Benzothiazoles; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Hematocrit; Hyperkinesis; Iron; Iron Metabolism Disorders; Polysomnography; Pramipexole; Rats; Rats, Sprague-Dawley; Restless Legs Syndrome

2017
Immediate resolution of acute, choreatic hyperkinesias following intravenous fentanyl.
    Nigerian journal of clinical practice, 2017, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Aged, 80 and over; Benzothiazoles; Chorea; Female; Fentanyl; Humans; Hyperkinesis; Pramipexole; Restless Legs Syndrome; Tramadol; Treatment Outcome

2017
Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3

    Topics: Animals; Antidepressive Agents; Benzothiazoles; Brain; Depression; Hyperkinesis; Male; Neuronal Plasticity; Olfactory Bulb; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Time Factors

2009
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride].
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:1

    Topics: Aconitate Hydratase; Animals; Antioxidants; Astrocytes; Benzothiazoles; Brain Chemistry; Cell Line, Tumor; Cerebellum; Culture Media; Dopamine Agonists; Hydrogen Peroxide; Hyperkinesis; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidants; Pramipexole; Stereoisomerism; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles

2006